Manchester Capital Management LLC Buys Shares of 6,909 Grail, Inc. (NASDAQ:GRAL)

Manchester Capital Management LLC bought a new stake in Grail, Inc. (NASDAQ:GRAL) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 6,909 shares of the company’s stock, valued at approximately $123,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in GRAL. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new stake in shares of Grail during the fourth quarter worth $244,000. Moloney Securities Asset Management LLC purchased a new stake in shares of Grail during the fourth quarter worth $559,000. Wesbanco Bank Inc. purchased a new stake in shares of Grail during the fourth quarter worth $523,000. Slow Capital Inc. purchased a new stake in shares of Grail during the fourth quarter worth $2,379,000. Finally, abrdn plc purchased a new stake in shares of Grail during the fourth quarter worth $3,768,000.

Grail Trading Up 4.6 %

Shares of GRAL stock opened at $55.02 on Friday. The firm has a fifty day moving average price of $23.94 and a 200 day moving average price of $18.11. Grail, Inc. has a 12 month low of $12.33 and a 12 month high of $55.32.

Insider Buying and Selling

In related news, CFO Aaron Freidin sold 30,452 shares of the business’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $14.02, for a total transaction of $426,937.04. Following the completion of the transaction, the chief financial officer now owns 268,277 shares in the company, valued at approximately $3,761,243.54. The trade was a 10.19 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Analyst Upgrades and Downgrades

GRAL has been the topic of a number of recent research reports. Morgan Stanley initiated coverage on Grail in a research report on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 price objective on the stock. Wolfe Research initiated coverage on Grail in a research report on Friday, November 15th. They set a “peer perform” rating on the stock.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.